Azitra, Other Wednesday, July 15, 2026 +0.30 Positive

Azitra Reports Positive Ex Vivo Filaggrin Distribution and Anti-Wrinkle Results

Azitra announced positive ex vivo results demonstrating increased penetration and anti-wrinkle efficacy for its filaggrin cosmetics program. These results indicate potential validation of the safety profile and commercial potential of their cosmetic division.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day